Certified IP diligence
Diligence your counterparty can check.
Verified by the reader, not by us.
Foster Rx assesses intellectual property and the deals attached to it, then signs the result. Your counterparty opens a link and verifies it themselves — no account, no fee, and nothing of ours in the path.
The problem
Analysis is cheap. Trust is expensive.
You send a valuation. The other side discounts it — not because it is wrong, but because they cannot check it. That discount is priced into every negotiation you enter, and machine-generated analysis is making it worse: more output, none of it signed, none of it anyone's responsibility.
See it
Three screens do most of the work.
A decision queue, not a dashboard
Your portfolio sorted by the decision that falls first — fee windows, prosecution clocks, responses due. Coverage travels with every row, so nothing is triaged against an unknown evidence base.
- Every material event resolves to a signed change or a logged dismissal
- Nothing is scored or ranked by importance
- An unassessed asset says so
A band with conditions, and the ask marked on it
Valuation is never a point estimate. It is a range against the derived value distribution for the domain, with its conditions enumerated and the asking price marked as a negotiating position rather than a verdict.
- Right-skewed distributions, so mean-anchored comparables overstate the median asset
- Every gap rendered with an explanation, never filled
- No certificate means no relation — the interface shows an em dash, never a default
Ask anything — and always know which answer counts
ANGIS answers instantly from the same records and the same methodologies, labelled unreviewed. When an answer has to count, send it for review: a named reviewer signs it and it issues as a certificate at a verifiable address.
- An unreviewed answer is structurally unable to carry a seal
- The label is architecture, not a disclaimer someone remembered to add
The platform
One engine. Two ways in.
Which view a client sees is configuration, not a different product. An assessment is produced by the same machinery whichever side of the table you sit on.
Thesis Rx
For technology transfer, biotech and device holders. Portfolio triage, monitored events, certified valuation and freedom-to-operate analysis.
Explore →
Capital Rx
For funds, family offices, corporate development and advisories. Pipeline by decision due, ask against band, evidence mapped with gaps stated.
Explore →
Underneath both sits the platform — how an assessment is produced and reviewed — and ANGIS, the in-product assistant whose answers arrive labelled unreviewed until a signed certificate stands behind them.
Honest by construction
Every gap is rendered. None is filled.
A diligence review covers twenty-five sections. Sections with nothing behind them are shown as such, with an explanation — the stated gap is often the most valuable line in the document.
Coverage never reads as provenance. Twenty-five complete sections is not a certification, and the two are never merged.
When we are wrong, we sign the correction. A superseding certificate is issued and the original stays verifiable. An attestation you can quietly delete was never an attestation.
Verification
What your counterparty sees
fosterrx.com/verify
- Open the linkNo account. No fee. Ever. The reader is never asked to register and never asked to pay.
- Check the signatureThe certificate verifies against a published trust anchor, with no Foster Rx server anywhere in the path.
- Read what we stand behindThe reviewer, the methods, the conditions — and the gaps we stated rather than filled.
Inside a certified assessment
Seven parts. Twenty-five sections. Every gap stated.
Every certified assessment follows a ratified architecture, and every statement in one is classified by what stands behind it. Four conventions govern the whole document; the full part-by-part architecture ships in the specimen, not here.
Reproduced exactly as recorded from a signed source. Never paraphrased, never improved on.
Arithmetic over enumerated inputs, recomputable by anyone holding the same record. The computation is named.
Reviewer synthesis, attributed and signed. Analysis is never presented as record.
Where the record supports nothing, the section says so and stays empty. A gap is rendered, never filled.
Request the specimen
A watermarked specimen of the full template — the complete section architecture and the honest-empty rendering included. Tell us who you are and the download opens; the same message reaches us so we can follow up properly. Handled under our privacy policy.
Open the specimen Download — Certified Reimbursement Diligence Assessment, specimen (PDF)Availability
What you can engage, and when
Certified reimbursement diligence for medical devices · certified IP valuation
Platform access opens for the founding cohort — Thesis Rx and Capital Rx
Freedom-to-operate claim analysis, first cohort — attorney-reviewed
The founding design-partner cohort closes. See the programme →
Let's talk
Bring us one asset with a live counterparty conversation.
We will certify it. Then send it to the person who was going to doubt you — that is the only test that matters, and it is the one we built for.